CHU de Bordeaux - Hôpital Haut Lévêque

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older	diffuse large B-cell lymphoma	Active, not recruiting	Phase 2	2026-06-04		NCT04974216
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation	B-Cell Lymphoma Refractory; B-cell Lymphoma Recurrent	Active, not recruiting	Phase 2	2026-03-27		NCT04531046

Clinical trials